Janos Nadas

891 total citations
24 papers, 722 citations indexed

About

Janos Nadas is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Janos Nadas has authored 24 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Janos Nadas's work include Immune Cell Function and Interaction (4 papers), Cancer therapeutics and mechanisms (4 papers) and T-cell and B-cell Immunology (4 papers). Janos Nadas is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Cancer therapeutics and mechanisms (4 papers) and T-cell and B-cell Immunology (4 papers). Janos Nadas collaborates with scholars based in United States, China and South Korea. Janos Nadas's co-authors include Zigang Dong, Ann M. Bode, Duxin Sun, Yong‐Yeon Cho, Benjamin P. Hay, Ke Yao, Peng George Wang, Dong Joon Kim, Naomi Oi and Angelo Pugliese and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Janos Nadas

24 papers receiving 714 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janos Nadas United States 16 437 130 121 86 57 24 722
Mi Young Han South Korea 17 367 0.8× 160 1.2× 81 0.7× 45 0.5× 85 1.5× 68 951
Saswati Banerjee United States 13 257 0.6× 165 1.3× 99 0.8× 85 1.0× 61 1.1× 31 725
Maocai Yan China 19 493 1.1× 166 1.3× 184 1.5× 48 0.6× 41 0.7× 57 852
Victor V. Tatarskiy Russia 18 423 1.0× 122 0.9× 142 1.2× 34 0.4× 19 0.3× 58 761
María Valcárcel Spain 18 378 0.9× 244 1.9× 133 1.1× 165 1.9× 113 2.0× 31 904
Ravindra Dhar Dubey India 18 394 0.9× 136 1.0× 67 0.6× 32 0.4× 32 0.6× 29 843
Hulai Wei China 18 423 1.0× 243 1.9× 137 1.1× 62 0.7× 59 1.0× 53 834
Gwénaël Chevé France 12 262 0.6× 82 0.6× 147 1.2× 74 0.9× 69 1.2× 20 547
Anupama Chaudhary India 4 386 0.9× 185 1.4× 156 1.3× 62 0.7× 19 0.3× 7 966

Countries citing papers authored by Janos Nadas

Since Specialization
Citations

This map shows the geographic impact of Janos Nadas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janos Nadas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janos Nadas more than expected).

Fields of papers citing papers by Janos Nadas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janos Nadas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janos Nadas. The network helps show where Janos Nadas may publish in the future.

Co-authorship network of co-authors of Janos Nadas

This figure shows the co-authorship network connecting the top 25 collaborators of Janos Nadas. A scholar is included among the top collaborators of Janos Nadas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janos Nadas. Janos Nadas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zykova, Tatyana A., Feng Zhu, Lei Wang, et al.. (2018). Targeting PRPK Function Blocks Colon Cancer Metastasis. Molecular Cancer Therapeutics. 17(5). 1101–1113. 15 indexed citations
2.
Roh, Eunmiri, Mee‐Hyun Lee, Tatyana A. Zykova, et al.. (2018). Targeting PRPK and TOPK for skin cancer prevention and therapy. Oncogene. 37(42). 5633–5647. 25 indexed citations
3.
Kim, Jung‐Hyun, Na‐Young Song, Jinyoung Suh, et al.. (2016). 15-Deoxy-Δ12,14-prostaglandin J2stabilizes hypoxia inducible factor-1α through induction of heme oxygenase-1 and direct modification ofprolyl-4-hydroxylase 2. Free Radical Research. 50(10). 1140–1152. 8 indexed citations
4.
Watson, L.A., et al.. (2013). Design Criteria for Polyazine Extractants To Separate AnIII from LnIII. Inorganic Chemistry. 52(18). 10632–10642. 51 indexed citations
5.
Hay, Benjamin P., Chuandong Jia, & Janos Nadas. (2013). Computer-aided design of host molecules for recognition of organic guests. Computational and Theoretical Chemistry. 1028. 72–80. 11 indexed citations
6.
Kim, Myoung Ok, Sung-Hyun Kim, Yong‐Yeon Cho, et al.. (2012). ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4. Nature Structural & Molecular Biology. 19(3). 283–290. 144 indexed citations
7.
Li, Xiang, Haitao Li, Shengqing Li, et al.. (2012). Ceftriaxone, an FDA-approved cephalosporin antibiotic, suppresses lung cancer growth by targeting Aurora B. Carcinogenesis. 33(12). 2548–2557. 25 indexed citations
8.
Chen, Hanyong, Ke Yao, Janos Nadas, et al.. (2012). Prediction of Molecular Targets of Cancer Preventing Flavonoid Compounds Using Computational Methods. PLoS ONE. 7(5). e38261–e38261. 36 indexed citations
9.
Nadas, Janos, Siniša Vukovič, & Benjamin P. Hay. (2012). Alkyl chlorides as hydrogen bond acceptors. Computational and Theoretical Chemistry. 988. 75–80. 14 indexed citations
10.
Kim, Dong Joon, Kanamata Reddy, Myoung Ok Kim, et al.. (2011). (3-Chloroacetyl)-indole, a Novel Allosteric AKT Inhibitor, Suppresses Colon Cancer Growth In Vitro and In Vivo. Cancer Prevention Research. 4(11). 1842–1851. 27 indexed citations
11.
Nadas, Janos, Xiaohua Zhang, & Benjamin P. Hay. (2011). Shapes of Sulfur, Oxygen, and Nitrogen Mustards. The Journal of Physical Chemistry A. 115(24). 6709–6716. 11 indexed citations
12.
Oi, Naomi, Chul‐Ho Jeong, Janos Nadas, et al.. (2011). Abstract 2884: Resveratrol, a red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A4 hydrolase. Cancer Research. 71(8_Supplement). 2884–2884. 1 indexed citations
13.
Oi, Naomi, Chul‐Ho Jeong, Janos Nadas, et al.. (2010). Resveratrol, a Red Wine Polyphenol, Suppresses Pancreatic Cancer by Inhibiting Leukotriene A4 Hydrolase. Cancer Research. 70(23). 9755–9764. 79 indexed citations
14.
Liu, Kangdong, Yong‐Yeon Cho, Ke Yao, et al.. (2010). Eriodictyol Inhibits RSK2-ATF1 Signaling and Suppresses EGF-induced Neoplastic Cell Transformation. Journal of Biological Chemistry. 286(3). 2057–2066. 52 indexed citations
15.
Zhang, Wenpeng, et al.. (2010). Introduction of aromatic group on 4′-OH of α-GalCer manipulated NKT cell cytokine production. Bioorganic & Medicinal Chemistry. 19(8). 2767–2776. 20 indexed citations
16.
Xia, Chengfeng, Wenpeng Zhang, Yalong Zhang, et al.. (2009). The Roles of 3′ and 4′ Hydroxy Groups in α‐Galactosylceramide Stimulation of Invariant Natural Killer T Cells. ChemMedChem. 4(11). 1810–1815. 19 indexed citations
17.
Chen, Wenlan, Chengfeng Xia, Jinhua Wang, et al.. (2008). Synthesis and Structure−Activity Relationship Study of Isoglobotrihexosylceramide Analogues. The Journal of Organic Chemistry. 73(12). 4762–4762. 1 indexed citations
18.
Nadas, Janos & Duxin Sun. (2006). Anthracyclines as effective anticancer drugs. Expert Opinion on Drug Discovery. 1(6). 549–568. 50 indexed citations
19.
Zhong, Yanqiang, Lanyan Fang, Seth Gibbs, et al.. (2006). Modifying the Sugar Moieties of Daunorubicin Overcomes P-gp-Mediated Multidrug Resistance. Molecular Pharmaceutics. 4(1). 140–153. 24 indexed citations
20.
Pan, Yanbin, et al.. (2004). Accessibility of N-acyl-d-mannosamines to N-acetyl-d-neuraminic acid aldolase. Carbohydrate Research. 339(12). 2091–2100. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026